YAP1 and cancer: We identified a total of 1251 and 1313 cancer patient samples carrying the oncogenic alterations for the Hippo pathway genes and YAP/TAZ/TEAD1-4, respectively (Supplementary Fig. 5a and Supplementary Data 4).